Drawing for WELLFISH

USPTO serial 79414454

WELLFISH

Reviewed by CopyMark Law Group

Reg. 8054813Status 700Registered
Filing date
Status date
Registration date
Dec 9, 2025
Examiner
MANCA, ALBERTO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WELLFISH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra MacKay

Alexandra MacKay Stites & Harbison PLLC401 Commerce StreetSuite 800Nashville, TN 37219

Goods and services

ClassDescriptionStatusFirst use
009Quantitative polymerase chain reaction (PCR) instruments being DNA detecting apparatus for scientific use; real-time polymerase chain reaction (PCR) instruments being DNA detecting apparatus for scientific use; research laboratory analysers for measuring, testing and analysing blood, serum and plasma; water quality monitoring and testing apparatus, namely, water testing instrumentation for monitoring and detecting contamination; apparatus for measuring algal bloom in water; downloadable software for collecting and interpreting clinical data; monitoring devices being electronic monitors for the aquaculture industry used to monitor animal health; downloadable software as a medical device (SaMD) for use as software applications for healthcare services in the field of aquaculture for analyzing health data of aquatic animals; artificial intelligence and machine learning software, namely, downloadable computer software using artificial intelligence for machine learning; downloadable artificial intelligence software for analysis of healthcare data; downloadable computer software for application and database integration; downloadable software incorporating algorithms for measuring, testing and analysing blood, serum and plasma; downloadable mobile applications for accessing fish health data reports; downloadable software platform for accessing and interacting with analysed data relating to fish health; downloadable reporting software for creating machine generated reports; downloadable electronic databases in the field of fish healthcare; downloadable database management software; laboratory apparatus and instruments, namely, microscopes, incubators for bacteria culture and medical research specimen collection devices in the nature of blood collection tubes; scientific laboratory research instruments for the detection of pathogens and toxins in a biological sample for research use; electric sensors; electric bio-sensorsACTIVE—
042Laboratory material testing services; biochemistry services, namely, bioorganic chemistry research and scientific laboratory services; biochemistry research services; environmental assessment services, namely, environmental testing and inspection services; water analysis; water quality monitoring and testing; water analysis, namely, measuring physical, chemical and environmental characteristics of water; water analysis, namely, measuring algal bloom in water; pathological testing for veterinary research purposes, namely, histopathology testing service for studying manifestations of disease in fish; scientific laboratory services, namely, laboratory research services using polymerase chain reaction (PCR) for pathogen identification in fish tissue, namely, blood samples; scientific laboratory services, namely, laboratory research and analysis services using biomarkers to investigate immune response following a health challenge; medical research services to investigate health challenges; software as a service (SAAS) services featuring software for collecting and interpreting clinical data; blood analysis services for scientific research purposes; technical data analysis services, namely, clinical research in the nature of data analysis of blood samples and fish tissue; scientific laboratory research and analysis in the field of chemistry endpoints; scientific chemical laboratory services; medical research laboratory services; veterinary research laboratory services; research laboratory analysis services in the field of fish health; biochemical analysis; biomedical research services; biological research laboratory services; biological research and medical research; clinical research in the field of fish health; chemical, biochemical, biological and bacteriological research and analysis; medical research laboratory services; scientific research and development services in the fields of biotechnology, bacteriology, immunology; research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; scientific analysis in the field of animal tissues for medical research; scientific study and research in the field of reproduction, husbandry, and general health of fish; chemical research and analysis services; chemistry services, namely, biochemical research relating to fish health; biochemical engineering services; toxicity analysis, namely, chemical analysis of the levels of toxicity in blood samples; scientific research consulting, namely, scientific risk assessment in relation to toxicological information; clinical research in the field of biomarkers for the purpose of assessing fish health; environmental surveying; scientific research and analysis services in the field of genotyping; technological analysis services, namely, computer analysis of blood samples for clinical research purposes to produce graphical reports relating to fish health; rental of laboratory apparatus and instruments; design, development and maintenance of software; development of mobile applications, being software; development and testing of computing methods and algorithms, namely, development and testing of software; software as a service (SAAS) services featuring computer software platforms using artificial intelligence for creating data reports on fish health; development of computer software platforms; development of online software platforms; platform as a service (PAAS) featuring computer software platforms for accessing and interacting with analysed data relating to fish health; programming of software for internet platforms for others; software as a service (SAAS) services featuring computer software platforms using artificial intelligence for analysing blood sample data; cross-platform conversion of digital content into other forms of digital content; research of artificial intelligence software; computer aided analysis services, namely, biochemical analysis; database development services; maintenance of database computer systems; web portal design being website design; hosting of portals being websites on the internet; consultancy, information and advisory services relating to all of the aforesaid servicesACTIVE—
044Services for the medical testing of blood; health assessment services for fish provided by clinical chemistry; medical analysis for the diagnosis and treatment of fish farmers; medical analysis services, namely, health reporting services provided to fish farmers for diagnosis and treatment purposes; health assessment services; medical laboratory services for the analysis of blood samples being medical analysis services for diagnostic treatment purposes provided by medical laboratories; veterinary analysis services relating to the medical treatment of aquatic livestock; veterinary laboratory analysis services relating to the treatment of animals; tissue typing services, namely, blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; veterinary laboratory analysis services relating to the treatment of animals, namely, analysis of animal tissues for medical treatment; clinical veterinary consultation services; medical consulting services in the field of disease infection control; provision of veterinary information in the fields of health, treatment and recovery of aquatic animals via a website of a global computer network; technical consultation in the fields of feeding and raising fish, shrimp and other farm-raised marine life; medical and veterinary screening; veterinary services; providing medical and veterinary support, namely, medical and veterinary diagnostic monitoring services in the nature of the monitoring of animal patients receiving treatments for health conditions; medical, veterinary and health assessment services relating to DNA, genetics and genetic testing; veterinary advice relating to the feeding of animals; aquaculture services, namely, the cultivation and breeding of animals in a water environment; veterinary advisory services relating to the care of fish; remote monitoring of medical data for medical diagnosis and treatment; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; immunodetection services for medical purposes; medical advice relating to immunology; rental of equipment for agriculture, aquaculture, horticulture and forestry; consultancy, information and advisory services relating to all of the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 25, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 21, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 21, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 8, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 8, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 9, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 21, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 21, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 5, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 5, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 8, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 8, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 21, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 20, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2025DOCKASSIGNED TO EXAMINER—
Jan 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance